MULTI-PROFESSIONAL COLLABORATION WITH HOME MEDICAL CARE FOR PALLIATIVE PERITONEAL DIALYSIS IN THE ELDERLY POPULATION

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 


 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/c0bcc9656bbfa3204c1002444e232442.pdf
MULTI-PROFESSIONAL COLLABORATION WITH HOME MEDICAL CARE FOR PALLIATIVE PERITONEAL DIALYSIS IN THE ELDERLY POPULATION

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Yukari
Kikuchi
Yukari Kikuchi kikuyuka@hosp.tohoku-mpu.ac.jp Tohoku Medical and Pharmaceutical University Division of Nephrology and Hypertension Sendai Japan * Tohoku Medical and Pharmaceutical University Division of Integrated Renal Replacement Therapy Sendai Japan
Tsubasa Yuki yuki.tsubasa@tohoku-mpu.ac.jp Tohoku Medical and Pharmaceutical University Division of Nephrology and Hypertension Sendai Japan - Tohoku Medical and Pharmaceutical University Division of Integrated Renal Replacement Therapy Sendai Japan
Hiroki Ito hito@tohoku-mpu.ac.jp Tohoku Medical and Pharmaceutical University Division of Nephrology and Hypertension Sendai Japan -
Katsuya Ishiyama ishiyama@tohoku-mpu.ac.jp Tohoku Medical and Pharmaceutical University Division of Nephrology and Hypertension Sendai Japan -
Takuo Hirose hirose.takuo@tohoku-mpu.ac.jp Tohoku Medical and Pharmaceutical University Division of Nephrology and Hypertension Sendai Japan - Tohoku Medical and Pharmaceutical University Division of Integrated Renal Replacement Therapy Sendai Japan
Ikuko Oba-Yabana iku-yabana@tohoku-mpu.ac.jp Tohoku Medical and Pharmaceutical University Division of Nephrology and Hypertension Sendai Japan - Tohoku Medical and Pharmaceutical University Division of Integrated Renal Replacement Therapy Sendai Japan
Takefumi Mori tmori@tohoku-mpu.ac.jp Tohoku Medical and Pharmaceutical University Division of Nephrology and Hypertension Sendai Japan - Tohoku Medical and Pharmaceutical University Division of Integrated Renal Replacement Therapy Sendai Japan
-
-
-
-
-
-
-
-

Palliative peritoneal dialysis (PD) is a patient-centered approach designed to manage symptoms and improve the quality of life for elderly individuals with advanced kidney disease. It emphasizes comfort and symptom control rather than disease cure, making it a suitable option for those who may not benefit from aggressive treatments. This modality allows for greater flexibility, often enabling patients to receive treatment in their homes with the support of a multi-professional team. However, its widespread adoption is often limited by the less extensive experience of home visiting nurses and home medical doctors with PD. To address this, a multi-professional PD assistance alliance was created. This study aimed to investigate whether multi-professional collaboration in PD—specifically between PD centers and home medical care—has beneficial roles in supporting palliative PD.

This retrospective study included 497 patients who received PD at Tohoku Medical and Pharmaceutical University Hospital between April 2016 and June 2025. Patients who were aged over 80 at the time of PD initiation and who died during this period were selected for analysis (n=83). Subjects were divided into two groups: the Home Medical Care Alliance (HMC) group (with a collaborative alliance among the PD professional center, home visiting nurses, and home medical doctors) or the Regular group (without this alliance). Peritoneal dialysis parameters were compared between the groups.

Of the 497 total PD patients, 83 met the inclusion criteria (age>80 at initiation and deceased within the study period). The HMC group comprised 66 patients, and the Regular group had 17 patients. The average age at PD initiation was comparable: 86±5 years in both the HMC and Regular groups. Similarly, the average age at the end of life (88±5 and 87±5 years, respectively) and PD vintage (HMC: 538±527 days; Regular: 374±373 days) were not significantly different. All patients in the HMC group selected palliative PD at the end of their lives. The total PD volume at the end of life was significantly lower in the HMC group (2.2±1.0 L) compared to the Regular group (3.8±2.0 L). The HMC group predominantly died in their accustomed community settings: 31 patients (47%) died at home and 17 (26%) died in a nursing home, totaling 73%. Conversely, the Regular group had a significantly higher proportion die in a hospital, with 16 patients (94%). While all 66 patients in the HMC group received nurse visits (100%), 13 patients (76%) in the Regular group also received visiting nurse care. Importantly, patients in the HMC group did not experience volume overload or severe uremic symptoms in their final stage.

This finding suggests that Home Medical Care Alliance (HMC) support, backed by medical institutions, significantly contributes to fulfilling patients' preferences for their place of end-of-life care and death under palliative PD.

Kewords